Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (551-560 of 663) with videos related to

Pageof 67
Sort By:
Heart (British Cardiac Society)|August 20, 2018
Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressureJoão Pedro Ferreira, Patrick Rossignol, Anne Pizard, et al.
BMJ (Clinical Research Ed.)|June 26, 2024
Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based studyNathalie Conrad, Geert Molenberghs, Geert Verbeke, et al.
Clinical Cardiology|September 16, 1999
Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD CouncilF W Verheugt, R C Becker, M E Bertrand, et al.
Journal of Cardiac Failure|August 22, 2021
Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure With Reduced Ejection FractionPhillip H Lam, Kalliopi Keramida, Gerasimos S Filippatos, et al.
International Journal of Cardiology|July 9, 2016
Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failureI Sokoreli, J J G de Vries, J M Riistama, et al.
European Journal of Heart Failure|December 24, 2016
Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million peopleStefan Koudstaal, Mar Pujades-Rodriguez, Spiros Denaxas, et al.
Heart Rhythm|February 6, 2017
The burden of proof: The current state of atrial fibrillation prevention and treatment trialsRosita Zakeri, David R Van Wagoner, Hugh Calkins, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 9, 2011
Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)Stephan von Haehling, Mitja Lainscak, Wolfram Doehner, et al.
Circulation. Heart Failure|November 22, 2021
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF TrialAkshay S Desai, Muthiah Vaduganathan, John G Cleland, et al.
Journal of Cardiac Failure|April 22, 2004
The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristicsBarry M Massie, William F Krol, Susan E Ammon, et al.
Pageof 67

Showing results (551-560 of 663) with videos related to

Sort By:
Pageof 67
Heart (British Cardiac Society)|August 20, 2018
Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressureJoão Pedro Ferreira, Patrick Rossignol, Anne Pizard, et al.
BMJ (Clinical Research Ed.)|June 26, 2024
Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based studyNathalie Conrad, Geert Molenberghs, Geert Verbeke, et al.
Clinical Cardiology|September 16, 1999
Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD CouncilF W Verheugt, R C Becker, M E Bertrand, et al.
Journal of Cardiac Failure|August 22, 2021
Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure With Reduced Ejection FractionPhillip H Lam, Kalliopi Keramida, Gerasimos S Filippatos, et al.
International Journal of Cardiology|July 9, 2016
Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failureI Sokoreli, J J G de Vries, J M Riistama, et al.
European Journal of Heart Failure|December 24, 2016
Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million peopleStefan Koudstaal, Mar Pujades-Rodriguez, Spiros Denaxas, et al.
Heart Rhythm|February 6, 2017
The burden of proof: The current state of atrial fibrillation prevention and treatment trialsRosita Zakeri, David R Van Wagoner, Hugh Calkins, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 9, 2011
Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)Stephan von Haehling, Mitja Lainscak, Wolfram Doehner, et al.
Circulation. Heart Failure|November 22, 2021
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF TrialAkshay S Desai, Muthiah Vaduganathan, John G Cleland, et al.
Journal of Cardiac Failure|April 22, 2004
The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristicsBarry M Massie, William F Krol, Susan E Ammon, et al.
Pageof 67